Kryger Capital’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History
Bought
Maintained
Sold
Kryger Capital's FMTX Position: Q4 2022 in Review
Kryger Capital sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 243,303 shares — an estimated $4.85M sold.
Kryger Capital first reported a position in FMTX in Q3 2022 and held it in 1 quarter. The position peaked at $4.85M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.
- Kryger Capital reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
- Kryger Capital sold 243,303 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $4.85M.
- Kryger Capital first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
- Kryger Capital's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $4.85M in Q3 2022.
- 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.
Based on Kryger Capital's 13F filing for Q4 2022, filed 14 Feb 2023.